A citation-based method for searching scientific literature

P Greenberg, C Cox, M M LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, T Vallespi, T Hamblin, D Oscier, K Ohyashiki, K Toyama, C Aul, G Mufti, J Bennett. Blood 1997
Times Cited: 3174







List of co-cited articles
705 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised international prognostic scoring system for myelodysplastic syndromes.
Peter L Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo Garcia-Manero, Francesc Solé, John M Bennett, David Bowen, Pierre Fenaux, Francois Dreyfus,[...]. Blood 2012
72

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
47

Clinical effect of point mutations in myelodysplastic syndromes.
Rafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, Naomi Galili, Björn Nilsson, Guillermo Garcia-Manero, Hagop Kantarjian, Azra Raza, Ross L Levine, Donna Neuberg,[...]. N Engl J Med 2011
23

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.
T Haferlach, Y Nagata, V Grossmann, Y Okuno, U Bacher, G Nagae, S Schnittger, M Sanada, A Kon, T Alpermann,[...]. Leukemia 2014
989
23

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, Sudhir Tauro, Gunes Gundem, Peter Van Loo, Chris J Yoon, Peter Ellis, David C Wedge, Andrea Pellagatti,[...]. Blood 2013
23

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Pierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan List,[...]. Lancet Oncol 2009
21

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.
Bruce D Cheson, Peter L Greenberg, John M Bennett, Bob Lowenberg, Pierre W Wijermans, Stephen D Nimer, Antonio Pinto, Miloslav Beran, Theo M de Witte, Richard M Stone,[...]. Blood 2006
21

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, Sean M Devlin, Heinz Tuechler, Juan S Medina-Martinez, Tetsuichi Yoshizato, Yusuke Shiozawa, Ryunosuke Saiki, Luca Malcovati,[...]. Nat Med 2020
175
19

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
Luca Malcovati, Ulrich Germing, Andrea Kuendgen, Matteo G Della Porta, Cristiana Pascutto, Rosangela Invernizzi, Aristoteles Giagounidis, Barbara Hildebrandt, Paolo Bernasconi, Sabine Knipp,[...]. J Clin Oncol 2007
755
18

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
Giulio Genovese, Anna K Kähler, Robert E Handsaker, Johan Lindberg, Samuel A Rose, Samuel F Bakhoum, Kimberly Chambert, Eran Mick, Benjamin M Neale, Menachem Fromer,[...]. N Engl J Med 2014
16

Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
16

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.
Pierre Fenaux, Uwe Platzbecker, Ghulam J Mufti, Guillermo Garcia-Manero, Rena Buckstein, Valeria Santini, María Díez-Campelo, Carlo Finelli, Mario Cazzola, Osman Ilhan,[...]. N Engl J Med 2020
195
16

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
R Coleman Lindsley, Wael Saber, Brenton G Mar, Robert Redd, Tao Wang, Michael D Haagenson, Peter V Grauman, Zhen-Huan Hu, Stephen R Spellman, Stephanie J Lee,[...]. N Engl J Med 2017
393
15

Treatment of MDS.
Uwe Platzbecker. Blood 2019
102
14

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.
Julie Schanz, Heinz Tüchler, Francesc Solé, Mar Mallo, Elisa Luño, José Cervera, Isabel Granada, Barbara Hildebrandt, Marilyn L Slovak, Kazuma Ohyashiki,[...]. J Clin Oncol 2012
432
13

Frequent pathway mutations of splicing machinery in myelodysplasia.
Kenichi Yoshida, Masashi Sanada, Yuichi Shiraishi, Daniel Nowak, Yasunobu Nagata, Ryo Yamamoto, Yusuke Sato, Aiko Sato-Otsubo, Ayana Kon, Masao Nagasaki,[...]. Nature 2011
12

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.
Uwe Platzbecker, Ulrich Germing, Katharina S Götze, Philipp Kiewe, Karin Mayer, Jörg Chromik, Markus Radsak, Thomas Wolff, Xiaosha Zhang, Abderrahmane Laadem,[...]. Lancet Oncol 2017
177
12

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, Tommaso Matteuzzi, Claudia Sala, Ettore Mosca, Chiara Chiereghin, Noemi Di Nanni, Matteo Gnocchi, Matteo Zampini,[...]. J Clin Oncol 2021
45
26

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
Luca Malcovati, Eva Hellström-Lindberg, David Bowen, Lionel Adès, Jaroslav Cermak, Consuelo Del Cañizo, Matteo G Della Porta, Pierre Fenaux, Norbert Gattermann, Ulrich Germing,[...]. Blood 2013
423
11

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.
Theo de Witte, David Bowen, Marie Robin, Luca Malcovati, Dietger Niederwieser, Ibrahim Yakoub-Agha, Ghulam J Mufti, Pierre Fenaux, Guillermo Sanz, Rodrigo Martino,[...]. Blood 2017
187
11

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
David P Steensma, Rafael Bejar, Siddhartha Jaiswal, R Coleman Lindsley, Mikkael A Sekeres, Robert P Hasserjian, Benjamin L Ebert. Blood 2015
11

Myelodysplastic syndromes.
Lionel Adès, Raphael Itzykson, Pierre Fenaux. Lancet 2014
268
10

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.
Hagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, John M Bennett, Maher Albitar, John DiPersio, Virginia Klimek, James Slack, Carlos de Castro, Farhad Ravandi,[...]. Cancer 2006
10

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Richard A Larson,[...]. Blood 2017
10

Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it.
Amer M Zeidan, Rory M Shallis, Rong Wang, Amy Davidoff, Xiaomei Ma. Blood Rev 2019
69
14

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
Courtney D DiNardo, Brian A Jonas, Vinod Pullarkat, Michael J Thirman, Jacqueline S Garcia, Andrew H Wei, Marina Konopleva, Hartmut Döhner, Anthony Letai, Pierre Fenaux,[...]. N Engl J Med 2020
672
10

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes.
David A Sallman, Amy E DeZern, Guillermo Garcia-Manero, David P Steensma, Gail J Roboz, Mikkael A Sekeres, Thomas Cluzeau, Kendra L Sweet, Amy McLemore, Kathy L McGraw,[...]. J Clin Oncol 2021
137
10

Genetics of MDS.
Seishi Ogawa. Blood 2019
143
9

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
James W Vardiman, Jüergen Thiele, Daniel A Arber, Richard D Brunning, Michael J Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M Le Beau, Eva Hellström-Lindberg, Ayalew Tefferi,[...]. Blood 2009
9

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, A Pellagatti, J S Wainscoat, E Hellstrom-Lindberg, C Gambacorti-Passerini,[...]. N Engl J Med 2011
872
9

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.
Hagop Kantarjian, Susan O'Brien, Farhad Ravandi, Jorge Cortes, Jianqin Shan, John M Bennett, Alan List, Pierre Fenaux, Guillermo Sanz, Jean-Pierre Issa,[...]. Cancer 2008
362
9

Causes of death in 2877 patients with myelodysplastic syndromes.
Kathrin Nachtkamp, Romina Stark, Corinna Strupp, Andrea Kündgen, Aristoteles Giagounidis, Carlo Aul, Barbara Hildebrandt, Rainer Haas, Norbert Gattermann, Ulrich Germing. Ann Hematol 2016
53
16

TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
Martin Jädersten, Leonie Saft, Alexander Smith, Austin Kulasekararaj, Sabine Pomplun, Gudrun Göhring, Anette Hedlund, Robert Hast, Brigitte Schlegelberger, Anna Porwit,[...]. J Clin Oncol 2011
337
9

Myelodysplastic Syndromes.
Mario Cazzola. N Engl J Med 2020
137
9

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.
Alan List, Gordon Dewald, John Bennett, Aristotle Giagounidis, Azra Raza, Eric Feldman, Bayard Powell, Peter Greenberg, Deborah Thomas, Richard Stone,[...]. N Engl J Med 2006
951
9

Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Mingchao Xie, Charles Lu, Jiayin Wang, Michael D McLellan, Kimberly J Johnson, Michael C Wendl, Joshua F McMichael, Heather K Schmidt, Venkata Yellapantula, Christopher A Miller,[...]. Nat Med 2014
9

Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.
A Nazha, M Narkhede, T Radivoyevitch, D J Seastone, B J Patel, A T Gerds, S Mukherjee, M Kalaycio, A Advani, B Przychodzen,[...]. Leukemia 2016
102
9

Clinical significance of somatic mutation in unexplained blood cytopenia.
Luca Malcovati, Anna Gallì, Erica Travaglino, Ilaria Ambaglio, Ettore Rizzo, Elisabetta Molteni, Chiara Elena, Virginia Valeria Ferretti, Silvia Catricalà, Elisa Bono,[...]. Blood 2017
255
8

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
Lewis R Silverman, Erin P Demakos, Bercedis L Peterson, Alice B Kornblith, Jimmie C Holland, Rosalie Odchimar-Reissig, Richard M Stone, Douglas Nelson, Bayard L Powell, Carlos M DeCastro,[...]. J Clin Oncol 2002
8


A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes.
U Platzbecker, A Symeonidis, E N Oliva, J S Goede, M Delforge, J Mayer, B Slama, S Badre, E Gasal, B Mehta,[...]. Leukemia 2017
65
12

Time-dependent changes in mortality and transformation risk in MDS.
Michael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz, Julie Schanz, Guillermo Garcia-Manero, Francesc Solé, John M Bennett, David Bowen, Pierre Fenaux, Francois Dreyfus,[...]. Blood 2016
93
8

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag, Odile Beyne-Rauzy, Ghulam Mufti, Moshe Mittelman, Petra Muus, Peter Te Boekhorst, Guillermo Sanz, Consuelo Del Cañizo,[...]. Blood 2011
332
8

Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN.
Elias Jabbour, Nicholas J Short, Guillermo Montalban-Bravo, Xuelin Huang, Carlos Bueso-Ramos, Wei Qiao, Hui Yang, Chong Zhao, Tapan Kadia, Gautam Borthakur,[...]. Blood 2017
103
8

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.
Detlef Haase, Ulrich Germing, Julie Schanz, Michael Pfeilstöcker, Thomas Nösslinger, Barbara Hildebrandt, Andrea Kundgen, Michael Lübbert, Regina Kunzmann, Aristoteles A N Giagounidis,[...]. Blood 2007
552
8

Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.
Rafael Bejar, Kristen E Stevenson, Bennett Caughey, R Coleman Lindsley, Brenton G Mar, Petar Stojanov, Gad Getz, David P Steensma, Jerome Ritz, Robert Soiffer,[...]. J Clin Oncol 2014
281
8

Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.
Tetsuichi Yoshizato, Yasuhito Nannya, Yoshiko Atsuta, Yusuke Shiozawa, Yuka Iijima-Yamashita, Kenichi Yoshida, Yuichi Shiraishi, Hiromichi Suzuki, Yasunobu Nagata, Yusuke Sato,[...]. Blood 2017
191
8

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
R Coleman Lindsley, Brenton G Mar, Emanuele Mazzola, Peter V Grauman, Sarah Shareef, Steven L Allen, Arnaud Pigneux, Meir Wetzler, Robert K Stuart, Harry P Erba,[...]. Blood 2015
505
8

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.
Luca Malcovati, Kristen Stevenson, Elli Papaemmanuil, Donna Neuberg, Rafael Bejar, Jacqueline Boultwood, David T Bowen, Peter J Campbell, Benjamin L Ebert, Pierre Fenaux,[...]. Blood 2020
109
8

Proposals for the classification of the myelodysplastic syndromes.
J M Bennett, D Catovsky, M T Daniel, G Flandrin, D A Galton, H R Gralnick, C Sultan. Br J Haematol 1982
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.